MARK A. GLICKMAN
Profile
First Name
: MARK
Middle Name
: A.
Last Name
: GLICKMAN
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
DIRECTOR
AKASH BAKSHI, ANDREW BARTYNSKI, CHARLES BISGAIER, LEE S. GOLDEN, JASON GROVES, JASON L. GROVES, STEVE GULLANS, STEPHEN HAAKENSON, P. KENT HAWRYLUK, RICHARD J. KANG, HYUNG HEON KIM, NA YEON KIM, KENNETH KOUSKY, ANDREW KOVEN, ANDREW I KOVEN, PEDRO LICHTINGER, DAVID LOWENSCHUSS, NADJA MANNOWETZ, JEFFREY MATHIESEN, MARGARET MCSHANE, JEONG GYUN OH, DANIELA ONICIU, SETH RENO, MICHAEL SALSBURY, ANDY SASSINE, NICOLA SHANNON, MINA SOOCH, D. GORDON STRICKLAND, DOUGLAS J. SWIRSKY, JAMES P. TURSI, MARSHALL H. WOODWORTH, AMY ZAREMBA RABOURN
DIRECTOR
AKASH BAKSHI, ANDREW BARTYNSKI, CHARLES BISGAIER, LEE S. GOLDEN, JASON GROVES, JASON L. GROVES, STEVE GULLANS, STEPHEN HAAKENSON, P. KENT HAWRYLUK, RICHARD J. KANG, HYUNG HEON KIM, NA YEON KIM, KENNETH KOUSKY, ANDREW KOVEN, ANDREW I KOVEN, PEDRO LICHTINGER, DAVID LOWENSCHUSS, NADJA MANNOWETZ, JEFFREY MATHIESEN, MARGARET MCSHANE, JEONG GYUN OH, DANIELA ONICIU, SETH RENO, MICHAEL SALSBURY, ANDY SASSINE, NICOLA SHANNON, MINA SOOCH, D. GORDON STRICKLAND, DOUGLAS J. SWIRSKY, JAMES P. TURSI, MARSHALL H. WOODWORTH, AMY ZAREMBA RABOURN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2025-05-08
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-06-23
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
$25,000,001 - $100,000,000
Debt
2016-02-05
